Mustafa S Vali
Deceased
from Baltimore, MD
- Also known as:
-
- Mustafa Shakir Vali
- Murtaza S Vali
- Shaki Vali Mustafa
- Vali Murtaza
- Phone and address:
- 234 Holliday St APT 201, Baltimore, MD 21202
Mustafa Vali Phones & Addresses
- 234 Holliday St APT 201, Baltimore, MD 21202
- Brooklyn, NY
Work
-
Position:Professional/Technical
Us Patents
-
Therapeutics For Cancer Using 3-Bromopyruvate And Other Selective Inhibitors Of Atp Production
view source -
US Patent:20100203110, Aug 12, 2010
-
Filed:Dec 17, 2007
-
Appl. No.:12/519957
-
Inventors:Jean-Francois Geschwind - Potomac MD, US
Mustafa Vali - Baltimore MD, US -
Assignee:The Johns Hopkins University - Baltimore MD
-
International Classification:A61K 38/21
A61K 31/19
A61K 31/53
A61K 38/50
A61K 35/74
A61K 31/255
A61K 31/282
A61K 31/195
A61K 31/7076
A61K 31/675
A61K 31/7068
A61K 31/655
A61K 38/12
A61K 31/65
A61K 31/573
A61K 31/7048
A61K 31/7072
A61K 31/513
A61K 31/437
A61K 31/519
A61K 31/429
A61K 31/52
A61K 31/475
A61K 9/127
A61P 35/00 -
US Classification:424450, 514557, 514245, 424 946, 424 9346, 514517, 514492, 514567, 514 46, 514 90, 514 49, 514151, 514 9, 514154, 514171, 514 27, 514 50, 514274, 424 857, 514283, 514249, 514368, 5142633, 514 83, 514285
-
Abstract:The present invention relates to methods of treating a cancerous tumor in a subject comprising administering to the subject an effective amount of 3-bromopyruvate. The 3-bromopyruvate may be administered intraarterially directly to a tumor as a continuous intraarterial infusion. The present invention also relates to methods for identifying agents that inhibit type II hexokinase activity.
-
Methods Of Treatment Using 3-Bromopyruvate And Other Selective Inhibitors Of Atp Production
view source -
US Patent:20130046019, Feb 21, 2013
-
Filed:Oct 23, 2012
-
Appl. No.:13/658696
-
Inventors:Mustafa Vali - Baltimore MD, US
-
Assignee:PRESCIENCE LABS, LLC - Wilmington DE
-
International Classification:A61K 31/19
A61P 31/04
A61P 31/10
A61P 17/02
A61P 33/00
A61P 35/00
A61P 29/00
A61P 31/00
A61P 31/12 -
US Classification:514557
-
Abstract:The present invention provides methods for preventing or treating infections, especially bacterial infections, by administering selective inhibitors of ATP production to inhibit glycolytic enzymes, such as glyceraldehyde 3-phosphate dehydrogenase (GAPDH). As such, the present invention further provides methods for preventing or treating inflammation and sepsis associated with infections, as well as increased wound healing and decreased wound scarring.
-
Methods And Compositions For Administration Of 3-Halopyruvate And Related Compounds For The Treatment Of Cancer
view source -
US Patent:20100137434, Jun 3, 2010
-
Filed:Aug 21, 2009
-
Appl. No.:12/583598
-
Inventors:Jean-Francois Geschwind - Potomac MD, US
Mustafa Vali - Baltimore MD, US -
International Classification:A61K 31/22
A61P 35/04 -
US Classification:514546
-
Abstract:The present disclosure relates to the discovery that compounds of the invention, particularly 3-bromopyruvate and related compounds, can be safely administered at concentrations effective for the treatment of cancer when formulated with an acidity of greater than or equal to pH of 2 and less than or equal to a pH of 6. Disclosed herein are novel and improved methods and compositions for the treatment of cancer using 3-halopyruvate and related compounds.
-
Methods And Compositions For Administration Of 3-Halopyruvate And Related Compounds For The Treatment Of Cancer
view source -
US Patent:20170224641, Aug 10, 2017
-
Filed:Oct 3, 2016
-
Appl. No.:15/284014
-
Inventors:- Baltimore MD, US
Mustafa Vali - Baltimore MD, US -
International Classification:A61K 31/19
A61K 47/02
A61K 45/06 -
Abstract:The present disclosure relates to the discovery that compounds of the invention, particularly 3-bromopyruvate and related compounds, can be safely administered at concentrations effective for the treatment of cancer when formulated with an acidity of greater than or equal to pH of 2 and less than or equal to a pH of 6. Disclosed herein are novel and improved methods and compositions for the treatment of cancer using 3-halopyruvate and related compounds.
-
Methods Of Treatment Using 3-Bromopyruvate And Other Selective Inhibitors Of Atp Production
view source -
US Patent:20150359764, Dec 17, 2015
-
Filed:Aug 26, 2015
-
Appl. No.:14/836649
-
Inventors:- Wilmington DE, US
Mustafa Vali - Baltimore MD, US -
International Classification:A61K 31/19
A01N 37/42
A61K 45/06 -
Abstract:The present invention provides methods for preventing or treating infections, especially bacterial infections, by administering selective inhibitors of ATP production to inhibit glycolytic enzymes, such as glyceraldehyde 3-phosphate dehydrogenase (GAPDH). As such, the present invention further provides methods for preventing or treating inflammation and sepsis associated with infections, as well as increased wound healing and decreased wound scarring.
Resumes
Chief Executive Officer
view sourceLocation:
Baltimore, MD
Industry:
Research
Work:
Positive Invention
Chief Executive Officer
Johns Hopkins School of Medicine
Associate Professor
Chief Executive Officer
Johns Hopkins School of Medicine
Associate Professor
Skills:
Research
Product Development
Science
Clinical
Patient Safety
Biotechnology
Oncology
Molecular Biology
Cancer
Drug Discovery
R&D
Clinical Development
Product Development
Science
Clinical
Patient Safety
Biotechnology
Oncology
Molecular Biology
Cancer
Drug Discovery
R&D
Clinical Development
Owner
view sourceLocation:
Baltimore, MD
Industry:
Entertainment
Work:
Red Maple
Owner
Owner
Education:
The Johns Hopkins University School of Medicine 1997 - 2007
Youtube
![Gus Vali - Mustafa [Chimera]](https://i.ytimg.com/vi/bUOXDmmVOgs/0.jpg "Gus Vali - Mustafa [Chimera]")
Googleplus
Mustafa Vali
Mustafa Vali Shaik
view source
Vali Mustafa
view source
Mustafa Vali
view source
Mustafa Vali
view source
Mustafa Vali
view sourceGet Report for Mustafa S Vali from Baltimore, MDDeceased